Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: J Am Acad Audiol. 2012 May;23(5):313–331. doi: 10.3766/jaaa.23.5.3

Table 1.

Participant Demographic Information

Participant Gender Etiology AAT LOIU (yrs) LOD (yrs) CNC (%)
1 M Usher II 51 5.0 33.9 44
2 F Unknown 46 7.5 13.3 66
3 F Otosclerosis 58 4.0 10.1 78
4 F Unknown 46 2.8 13.0 86
5 F Genetic 52 4.2 5.4 90
6 F Genetic 57 6.2 12.8 71
7 M Unknown 72 8.2 4.1 78
8 M Genetic 55 10.6 5.9 84
9 M Otosclerosis 74 5.1 14.4 82
10 F Genetic (AIED) 48 4.5 5.5 48
11 F Unknown 38 1.2 2.7 74
12 F Genetic 70 1.1 10.2 83
13 F Unknown 72 1.6 15.5 81
14 M MS 49 3.4 3.7 86
15 M Genetic 71 1.5 4.0 92
16 F Unknown 54 2.2 28.9 59
17 M Noise 65 3.0 4.1 58
18 F Unknown 78 3.7 2.3 62
19 F Unknown 75 2.9 0.4 58
20 F Unknown 58 0.8 6.8 68
21 F Ototoxicity 25 2.2 12.1 79
22 F Genetic 57 3.9 10.6 80

Note: AAT = age at test; LOD = length of auditory deprivation; LOIU = length of implant use; CNC = most recent word score on Consonant Vowel-Nucleus Consonant test; AIED = Autoimmune Inner Ear Disease; MS = Multiple Sclerosis